Northwestern Mutual Wealth Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SNDX
KCM
VCM
DM
EP
KCM
HRCM
Northwestern Mutual Wealth Management's SNDX Position: Q1 2026 in Review
Northwestern Mutual Wealth Management opened a new position in Syndax Pharmaceuticals (SNDX) in Q1 2026: 74 shares worth $1.73K. The stake represents ﹤0.01% of the portfolio and ranks #3639 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in SNDX as recently as Q2 2024.
Northwestern Mutual Wealth Management first reported a position in SNDX in Q4 2023 and has held it in 3 quarters since. The position peaked at $26.7K in Q2 2024. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.
- Northwestern Mutual Wealth Management held 74 shares of Syndax Pharmaceuticals worth $1.73K as of Q1 2026.
- Syndax Pharmaceuticals was a new Northwestern Mutual Wealth Management position in Q1 2026.
- Syndax Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3639 holding.
- Northwestern Mutual Wealth Management first reported a position in Syndax Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
- Northwestern Mutual Wealth Management's Syndax Pharmaceuticals position peaked at $26.7K in Q2 2024.
- 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.